Advanced Medical Solutions Grp PLC
23 April 2002
For Immediate Release: 23 April 2002
Advanced Medical Solutions Group plc ('AMS' or the 'Company')
Result of the Extraordinary General Meeting
AMS announces that at the Extraordinary General Meeting of the Company held
earlier today, the resolutions put to shareholders of the Company to approve,
inter alia, the acquisition of MedLogic Global Holdings Limited (and related
intellectual property assets), the VCT placing, the open offer and a share
capital reorganisation were duly passed.
Commenting on the results of the Extraordinary General Meeting and on the
Acquisition, Dr. Don Evans, Group Chief Executive, said:
'I am delighted that our shareholders have approved the acquisition of the
MedLogic business. Now that profitability is in sight for our existing
woundcare business, this acquisition provides an opportunity to accelerate
growth in revenues and earnings for the future. It is an excellent strategic
fit, which helps to move us to higher value products and the response to this
deal from our customer base has been extremely positive'.
- ENDS -
For further enquiries:
Advanced Medical Solutions Group plc Robert W. Baird Limited
Don Evans (Group Chief Executive) Shaun Dobson
Mary Tavener (Finance Director) Xavier de Mol
Tel: 01606 863 500 Tel: 020 7488 1212
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.